Granahan Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-405,247
| Closed | -$1.04M | – | 191 |
|
|
2022
Q1 | $1.04M | Sell |
405,247
-119,365
| -23% | -$305K | 0.03% | 172 |
|
|
2021
Q4 | $1.54M | Buy |
524,612
+59,563
| +13% | +$175K | 0.03% | 179 |
|
|
2021
Q3 | $1.14M | Buy |
465,049
+14,635
| +3% | +$35.8K | 0.02% | 186 |
|
|
2021
Q2 | $1.83M | Buy |
450,414
+16,704
| +4% | +$68K | 0.03% | 180 |
|
|
2021
Q1 | $1.96M | Buy |
433,710
+121,120
| +39% | +$546K | 0.04% | 172 |
|
|
2020
Q4 | $1.54M | Sell |
312,590
-33,838
| -10% | -$166K | 0.03% | 180 |
|
|
2020
Q3 | $2.05M | Buy |
346,428
+6,025
| +2% | +$35.7K | 0.07% | 152 |
|
|
2020
Q2 | $905K | Buy |
+340,403
| New | +$905K | 0.03% | 172 |
|
|
2019
Q1 | – | Sell |
-82,504
| Closed | -$1.4M | – | 203 |
|
|
2018
Q4 | $1.4M | Sell |
82,504
-48,641
| -37% | -$827K | 0.1% | 149 |
|
|
2018
Q3 | $2.31M | Buy |
131,145
+445
| +0.3% | +$7.83K | 0.13% | 147 |
|
|
2018
Q2 | $2.48M | Buy |
+130,700
| New | +$2.48M | 0.15% | 150 |
|